Clinical Trials on Indolent Lymphoproliferative Disorders
Total 143717 results
-
Central Hospital, Nancy, FranceUnknown
-
Mayo ClinicNot yet recruitingIndolent B-Cell Non-Hodgkin Lymphoma | Recurrent Indolent Non-Hodgkin Lymphoma | Refractory Indolent Non-Hodgkin Lymphoma | Recurrent Indolent B-Cell Non-Hodgkin Lymphoma | Refractory Indolent B-Cell Non-Hodgkin LymphomaUnited States
-
Fondazione Italiana Linfomi - ETSActive, not recruitingIndolent B-Cell LymphomasFrance, Italy, Brazil, Austria, Portugal, Ukraine
-
University of Michigan Rogel Cancer CenterBristol-Myers Squibb; Bayer; University of Michigan; Big Ten Cancer Research ConsortiumActive, not recruiting
-
German Low Grade Lymphoma Study GroupTerminatedIndolent LymphomaGermany
-
Prof. Dr. Wolfgang HiddemannHoffmann-La Roche; Mundipharma Research GmbH & Co KGCompleted
-
Tel-Aviv Sourasky Medical CenterKaMaH - The Center for Health-Promoting TherapiesRecruitingIndolent LymphomaIsrael
-
Cancer Institute and Hospital, Chinese Academy...Shanxi Province Cancer Hospital; Beijing Tongren Hospital; Fujian Medical University...Recruiting
-
Shanghai YingLi Pharmaceutical Co. Ltd.Not yet recruitingIndolent B-cell Lymphoma
-
SecuraBioCompletedIndolent Non-Hodgkin LymphomaKorea, Republic of, Czechia, United States, United Kingdom, Italy, Poland, Russian Federation, Germany
-
PrECOG, LLC.Genentech, Inc.TerminatedIndolent Non-Hodgkin's LymphomaUnited States
-
Gruppo Italiano Studio LinfomiUnknown
-
Fondazione Italiana Linfomi ONLUSCompletedNon-Hodgkin's Lymphoma | Indolent Non-follicularItaly
-
Ludwig-Maximilians - University of MunichHoffmann-La Roche; Janssen-Cilag G.m.b.HActive, not recruitingIndolent Non-Hodgkin LymphomaGermany
-
SecuraBioCompletedIndolent Non-Hodgkin LymphomaBelgium, France, Italy, Spain, Canada, United States, Bulgaria, United Kingdom, Hungary, Georgia, Belarus, Czechia
-
National Taiwan University HospitalUnknown
-
Hebei Senlang Biotechnology Inc., Ltd.RecruitingRefractory Indolent Adult Non-Hodgkin LymphomaChina
-
Gilead SciencesTerminatedIndolent Non-Hodgkin's LymphomasUnited States, Korea, Republic of, Hungary, United Kingdom, Australia, Singapore, Japan, Taiwan, Israel, Italy, Spain, Czechia, Russian Federation, France, Poland, Romania, Germany, Portugal, Sweden
-
Huiqiang HuangRecruitingLymphoma, B-CellChina
-
BayerActive, not recruitingRelapsed or Refractory Indolent Non-Hodgkin LymphomaTaiwan
-
S*BIOCompletedHodgkin Lymphoma | Mantle Cell Lymphoma | Indolent LymphomaUnited States, Canada
-
GlaxoSmithKlineCompleted
-
Gilead SciencesTerminatedIndolent Non-Hodgkin's LymphomasUnited States, Korea, Republic of, Canada, Spain, Taiwan, France, Australia, United Kingdom, Poland, Italy, Israel, Czechia, Germany, Russian Federation, Sweden
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.; Brigham and Women's HospitalCompletedB-cell Lymphoma | Indolent B-cell LymphomaUnited States
-
Ronald LevyPfizerCompletedLymphoma | Lymphoma, Non-Hodgkin | Lymphomas: Non-Hodgkin | Lymphomas: Non-Hodgkin Follicular / Indolent B-CellUnited States
-
Mundipharma Research LimitedTerminatedIndolent B-cell NHLAustralia, Slovakia
-
Brian HillThe Cleveland ClinicTerminatedLymphoma | B Cell LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedIndolent Non-Hodgkin's LymphomaUnited States
-
Kyowa Kirin Co., Ltd.Active, not recruitingStudy of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma (NHL)Indolent B-cell Non-Hodgkin's LymphomaJapan
-
SandozNovartis PharmaceuticalsCompletedIndolent B-cell Non-Hodgkin's LymphomaJapan
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Celgene CorporationCompletedRefractory/Relapsed Indolent Non-Hodgkin LymphomaUnited States
-
BioInvent International ABRecruitingIndolent B-Cell Non-Hodgkin LymphomaSpain, United States, Brazil, Sweden, Germany, Poland
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.CompletedIndolent B-Cell Non-Hodgkin's LymphomasChina
-
University of ArizonaNational Cancer Institute (NCI)CompletedLymphoma | Mantle Cell Lymphoma | Indolent Lymphoma | SLLUnited States
-
Millennium Pharmaceuticals, Inc.CompletedFollicular Lymphoma | B-Cell Lymphoma | Marginal LymphomaUnited States
-
Dana-Farber Cancer InstituteHiberCell, Inc.CompletedRelapsed/Refractory Indolent B Cell Non-Hodgkin LymphomasUnited States
-
University Hospital, ToulouseRecruitingMastocytosis, Indolent SystemicFrance
-
Innovent Biologics (Suzhou) Co. Ltd.Active, not recruitingIndolent Non-hodgkin LymphomaChina
-
Kyowa Kirin Co., Ltd.Active, not recruitingRelapsed or Refractory Indolent B-cell Non-Hodgkin's LymphomaJapan
-
Yogen SaunthararajahCompletedT-cell Lymphoma | Indolent B-cell Lymphoma | Aggressive B-cell Lymphoma | Non-Hodgkin's LymphomasUnited States
-
Century Therapeutics, Inc.RecruitingAggressive Non-Hodgkin Lymphoma | R/R CD19-Positive B-Cell Malignancies | Indolent Non-Hodgkin LymphomaUnited States
-
University of WashingtonMerck Sharp & Dohme LLCActive, not recruitingFollicular Lymphoma | Marginal Zone Lymphoma | Indolent B-Cell Non-Hodgkin LymphomaUnited States
-
CHU de ReimsUnknownIndolent Cutaneous B Cell LymphomasFrance
-
Altor BioScienceTerminatedRelapsed/Refractory Indolent B Cell Non-Hodgkin LymphomaUnited States
-
Lundbeck Canada Inc.CompletedChronic Lymphocytic Leukemia | Indolent Non-Hodgkin's LymphomaCanada
-
UNC Lineberger Comprehensive Cancer CenterGlaxoSmithKlineWithdrawnLymphoma, Follicular | Lymphoma, Non-Hodgkin | Lymphoma, B-Cell, Marginal Zone | Lymphoma, Low-Grade | Lymphoma, Intermediate-Grade
-
National Cancer Institute (NCI)WithdrawnLocally Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Aggressive Non-Hodgkin Lymphoma | Indolent Non-Hodgkin LymphomaUnited States
-
Medivation, Inc.WithdrawnLymphoma, Large B-Cell, Diffuse | Primary Mediastinal Large B-cell Lymphoma | Transformed Indolent LymphomaUnited States
-
Nektar TherapeuticsCompletedMultiple Myeloma | Non-Hodgkin Lymphoma | Indolent Non-Hodgkin LymphomaUnited States
-
Kite, A Gilead CompanyActive, not recruitingFollicular Lymphoma | Marginal Zone Lymphoma | Indolent Non-Hodgkin LymphomaUnited States, France